Steven Berney, MD Professor Emeritus, Medicine Temple University School of Medicine Section of Rheumatology Philadelphia, PA
AMA PRA Category 1 Credit TM Medium
Rheumatoid arthritis (RA) is a chronic inflammatory disease that causes joint pain, stiffness, and swelling, and increases the risk of systemic conditions such as cardiovascular disease. RA currently affects 1.3 million people in the United States, and the incidence of RA is on the rise in women. Without early treatment that emphasizes tight control of disease activity, RA progresses to cause joint destruction, decreased physical functioning, and reduced quality of life. Therefore, early treatment initiation and ongoing monitoring of therapeutic response are critical to improving patient outcomes.
Treat-to-target (T2T) is a consensus and evidence-based strategy to treating patients with RA. In this interactive newsletter, faculty provide information on the framework for T2T. A patient case is presented to illustrate and stress the key principles and recommendations of T2T.
Rheumatologists, primary care physicians, nurse practitioners, physician assistants and other health care clinicians interested and involved in the treatment of patients with RA.
Upon completion of this educational activity, the participant should be able to:
Describe why and how T2T is used in managing patients with RA.
Summarize evidence-based T2T strategies in RA, including disease-activity monitoring and treatment modification for patients with inadequate therapeutic response.
Incorporate T2T strategies into clinical practice to optimize management of patients with RA.
It is the policy of Temple University School of Medicine; The Albert J. Finestone, MD Office for Continuing Medical Education to insure balance, independence, objectivity, and scientific rigor in all of its sponsored or jointly sponsored educational programs. All faculty, program planning committee members, and Temple University School of Medicine Continuing Medical Education staff participating in programs sponsored or jointly sponsored by Temple University School of Medicine are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).
PLANNING COMMITTEE DISCLOSURE STATEMENT
Planning committee members have no financial relationships to disclose.
FACULTY DISCLOSURE STATEMENT
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Temple University School of Medicine, Temple University Health System or its affiliates. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Dr. Berney has no relevant financial relationships to disclose.
Accreditation Statement: Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education for physicians.
Certification Statement: Temple University School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There is no fee to participate and receive credit.
Credit Provider Contact Information
School of Medicine
The Albert J. Finestone, MD Office for CME
3500 North Broad Street Philadelphia, PA 19140
Commercial Support Statements
This activity is supported through an independent educational grant from Abbott Laboratories.
This activity is supported through an independent educational grant from Amgen Inc.
Minimum System Requirements:
• Pentium III, 600 MHz or Equivalent Processor
• 512 MB of RAM
• Windows XP, Vista, or 7
• Mac OS X
• 800x600 Monitor Resolution
• 16-bit Color
• 16 bit Sound Card with Speakers
There are no fees for participating in or receiving credit for this online educational activity.
This activity is designed to be completed within the time designated on this page; physicians should claim only those credits that reflect the time actually spent in the activity. Study the educational content online.
After you have finished the activity, click on the "Post-test" button. Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen. A credit statement/certificate will be awarded for a score of 65% or better and may be printed immediately after passing the post-test.
Copyright © 2013. Temple University School of Medicine. All rights reserved.
Presented by Temple University School of Medicine and MCM Education.
The opinions expressed in these educational activities are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Temple University School of Medicine, Abbott Laboratories or Amgen Inc. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.
To view our privacy policies, please visit: http://www.cmecorner.com/privacy.asp